Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmaceutical companies

UN chief lauds Pfizer’s decision to ban use of its drugs in executions

Zeid Ra'ad Al Hussein

Source: John Zarocostas

Zeid Ra’ad Al Hussein says US states should not resort to questionable sources for the drugs required to administer lethal injections

The United Nations high commissioner for human rights has praised pharmaceutical company Pfizer’s decision to ban the sale and distribution of its drugs to prisons for use in executions by lethal injection.

“Business, across many industries, can help prevent human rights violations,” Zeid Ra’ad Al Hussein said in a statement on 19 May 2016. “It is heartening to see companies playing an active role in furthering the trend towards ending the use of the death penalty.”

On 13 May 2016, Pfizer announced the ban that will apply to seven drugs used in lethal injections in some US states: propofol, pancuronium bromide, midazolam, hydromorphone, rocuronium bromide, vecuronium bromide and potassium chloride.

Pfizer says the controls will “limit the sale of the seven products to a select group of wholesalers, distributors and direct purchasers under the condition they will not resell these products to correctional institutions for use in lethal injections”.

Its company guidelines also stipulate that government purchasing entities “must certify that products they purchase or otherwise acquire are used only for medically prescribed patient care and not for any penal purposes”.

Zeid says US states should not resort to questionable sources for the drugs required to administer lethal injections, and underscored the UN opposition to the death penalty in all circumstances.

Lack of access to drugs for use in lethal injections and some botched executions has led some states, such as New Jersey, to repeal the death penalty and some to defer executions.

In March 2015, the American Pharmacists Association adopted a policy that “discourages pharmacist participation in executions on the basis that such activities are fundamentally contrary to the role of pharmacists as providers of health care”.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201201

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Patient Care in Community Practice

    Patient Care in Community Practice

    Patient Care in Community Practice is a unique, practical guide for healthcare professionals or carers. Covers a range of non-medicinal products suitable for use at home.

    £22.00Buy now
  • Clinical Pharmacokinetics

    Clinical Pharmacokinetics

    A practical guide to the use of pharmacokinetic principles in clinical practice. Includes case studies with questions and answers.

    £33.00Buy now
  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Pharmaceutical Toxicology

    Pharmaceutical Toxicology

    Explains the methodology and requirements of pre-clinical safety assessments of new medicines. Includes registration requirements and pharmacovigilance.

    £40.00Buy now
  • Strategic Medicines Management

    Strategic Medicines Management

    A practical guide to influencing the availability of medicines, and policies of their use. Focuses on the strategic elements of medicines management.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Zeid Ra'ad Al Hussein

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.